Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry.

Saved in:
Bibliographic Details
Title: Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry.
Authors: Yu C; Department of Dermatology, Xijing Hospital, The Fourth Military Medical University, No. 127 Changle West Rd, Xi'an, 710032, People's Republic of China., Wang G; Department of Dermatology, Xijing Hospital, The Fourth Military Medical University, No. 127 Changle West Rd, Xi'an, 710032, People's Republic of China. xjwgang@fmmu.edu.cn., Burge RT; Eli Lilly and Company, Indianapolis, IN, USA., Ye E; Eli Lilly and Company, Shanghai, People's Republic of China., Dou G; Eli Lilly and Company, Shanghai, People's Republic of China., Li J; Eli Lilly and Company, Shanghai, People's Republic of China., Harrison RW; CorEvitas, LLC, Waltham, MA, USA., McLean RR; CorEvitas, LLC, Waltham, MA, USA., Kerti SJ; CorEvitas, LLC, Waltham, MA, USA., Bagel J; Psoriasis Treatment Center of New Jersey, East Windsor, NJ, USA.
Source: Dermatology and therapy [Dermatol Ther (Heidelb)] 2023 Jan; Vol. 13 (1), pp. 187-206. Date of Electronic Publication: 2022 Nov 16.
Publication Type: Journal Article
Journal Info: Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2193-8210
DOI:10.1007/s13555-022-00843-6